BSB
REGN icon

Bangor Savings Bank’s Regeneron Pharmaceuticals REGN Stock Holding History

Bangor Savings Bank’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$650K Hold
857
– – 0.05% 136
2026
Q2 		$534K Hold
857
– – 0.04% 156
2026
Q1 		$662K Hold
857
– – 0.05% 133
2025
Q4 		$661K Hold
857
– – 0.05% 133
2025
Q3 		$482K Sell
857
-30
-3% -$17K 0.04% 164
2025
Q2 		$466K Hold
887
– – 0.04% 160
2025
Q1 		$563K Sell
887
-65
-7% -$44.7K 0.05% 152
2024
Q4 		$678K Sell
952
-64
-6% -$53.7K 0.06% 136
2024
Q3 		$1.07M Hold
1,016
– – 0.1% 104
2024
Q2 		$1.07M Buy
1,016
+16
+2% +$15.5K 0.11% 106
2024
Q1 		$962K Hold
1,000
– – 0.1% 115
2023
Q4 		$878K Hold
1,000
– – 0.1% 117
2023
Q3 		$823K Hold
1,000
– – 0.1% 120
2023
Q2 		$719K Hold
1,000
– – 0.08% 133
2023
Q1 		$822K Hold
1,000
– – 0.1% 120
2022
Q4 		$721K Hold
1,000
– – 0.09% 127
2022
Q3 		$689K Buy
+1,000
New +$629K 0.08% 131

Other funds holding REGN

GA
GuoLine Advisory Singapore $1.16B AUM 31.35% 1-Year Est. Return
AP
Atwood & Palmer Kansas City, Missouri $1.95B AUM 16% 1-Year Est. Return
MSV
MN Services Vermogensbeheer The Hague, Netherlands $13.4B AUM 37.34% 1-Year Est. Return
SBWIC
Schaper Benz & Wise Investment Counsel Neenah, Wisconsin $1.51B AUM 27.44% 1-Year Est. Return
NPPM
North Point Portfolio Managers Orange Village, Ohio $595M AUM 14.89% 1-Year Est. Return
JC
Jacobs & Co San Francisco, California $1.16B AUM 34.03% 1-Year Est. Return
MPWT
MassMutual Private Wealth & Trust Windsor, Connecticut $3.79B AUM 19.33% 1-Year Est. Return
IWS
Insight Wealth Strategies San Ramon, California $1.01B AUM 28.81% 1-Year Est. Return
VC
Veracity Capital Atlanta, Georgia $372M AUM 32.95% 1-Year Est. Return
CPBTD
Central Pacific Bank - Trust Division Honolulu, Hawaii $952M AUM 25.15% 1-Year Est. Return

Bangor Savings Bank's REGN Position: Q3 2026 in Review

Bangor Savings Bank held its Regeneron Pharmaceuticals (REGN) position steady in Q3 2026 at 857 shares worth $650K. The position accounts for 0.05% of the portfolio, ranked #136.

Bangor Savings Bank first reported a position in REGN in Q3 2022 and has held it in 17 quarters since. The position peaked at $1.07M in Q3 2024. 54 funds tracked by Wall St. Rank hold REGN as of Q3 2026.

  • Bangor Savings Bank held 857 shares of Regeneron Pharmaceuticals worth $650K as of Q3 2026.
  • Bangor Savings Bank left its Regeneron Pharmaceuticals share count unchanged in Q3 2026.
  • Regeneron Pharmaceuticals made up 0.05% of Bangor Savings Bank's portfolio in Q3 2026, its #136 holding.
  • Bangor Savings Bank first reported a position in Regeneron Pharmaceuticals in Q3 2022 and has held it in 17 quarters since.
  • Bangor Savings Bank's Regeneron Pharmaceuticals position peaked at $1.07M in Q3 2024.
  • 54 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q3 2026.

Based on Bangor Savings Bank's 13F filing for Q3 2026, filed 6 Oct 2026.